tiprankstipranks
Advertisement
Advertisement

CRMD Stock Latest News

Cormedix Earnings Call Highlights Surging Growth, New Risks
Company AnnouncementsCormedix Earnings Call Highlights Surging Growth, New Risks
1d ago
CRMD
Cormedix Earnings Call Highlights Growth, Raises Outlook
PremiumCompany Announcements
Cormedix Earnings Call Highlights Growth, Raises Outlook
6d ago
CRMD
Analyst Reiterates Buy on Cormedix, Maintains Unchanged $13 Price Target Amid Strengthening Commercial Execution and Pipeline Prospects
PremiumRatings
Analyst Reiterates Buy on Cormedix, Maintains Unchanged $13 Price Target Amid Strengthening Commercial Execution and Pipeline Prospects
7d ago
CRMD
3 Low P/E Stocks with Over 40% Upside
PremiumMarket News
3 Low P/E Stocks with Over 40% Upside
7d ago
CRMD
OPRA
CorMedix reports Q1 EPS 43c, consensus 33c
PremiumThe Fly
CorMedix reports Q1 EPS 43c, consensus 33c
7d ago
CRMD
CorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M
PremiumThe FlyCorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M
7d ago
CRMD
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
16d ago
CRMD
3 Best Cheap Stocks Under $10 Worth Watching in May 2026
Premium
Market News
3 Best Cheap Stocks Under $10 Worth Watching in May 2026
19d ago
ACHR
CRMD
Citizens healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens healthcare analysts hold an analyst/industry conference call
22d ago
CRMD
CorMedix price target raised to $14 from $13 at RBC Capital
PremiumThe Fly
CorMedix price target raised to $14 from $13 at RBC Capital
23d ago
CRMD
Buy Rating Reiterated on REZZAYO Trial Strength and Safety Profile; $13 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on REZZAYO Trial Strength and Safety Profile; $13 Price Target Maintained
23d ago
CRMD
CorMedix Reports Positive Phase III REZZAYO Prophylaxis Results
PremiumCompany Announcements
CorMedix Reports Positive Phase III REZZAYO Prophylaxis Results
24d ago
8K
CRMD
CorMedix announces ReSPECT clinical trial met primary endpoint
PremiumThe FlyCorMedix announces ReSPECT clinical trial met primary endpoint
24d ago
CRMD
3 ‘Strong Buy’ Low P/E Stocks with Over 40% Upside
Premium
Market News
3 ‘Strong Buy’ Low P/E Stocks with Over 40% Upside
1M ago
GEO
CRMD
Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
Premium
Ratings
Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
1M ago
CRMD
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
PremiumCompany Announcements
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
2M ago
CRMD
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
PremiumCompany Announcements
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
3M ago
8K
CRMD
CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M
PremiumThe Fly
CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M
3M ago
CRMD
CorMedix price target lowered to $13 from $15 at Leerink
PremiumThe Fly
CorMedix price target lowered to $13 from $15 at Leerink
3M ago
CRMD
Buy Rating Maintained as Long-Term Rezzayo Upside Remains Underappreciated Despite Near-Term Weakness
PremiumRatingsBuy Rating Maintained as Long-Term Rezzayo Upside Remains Underappreciated Despite Near-Term Weakness
3M ago
CRMD
CorMedix reports Q4 EPS 16c vs 20c last year
Premium
The Fly
CorMedix reports Q4 EPS 16c vs 20c last year
3M ago
CRMD
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CRMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >